Pancreatic Cancer Research

ResearcherHudsonAlpha Institute for BiotechnologyNo recent work listed

Emily R. Gordon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0838-7110; OpenAlex author ID A5057634971. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers

Papers 3

  1. Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance. Co-author DOI 10.1186/s12885-023-11010-1↗
  2. Genomic analysis reveals HDAC1 regulates clinically relevant transcriptional programs in Pancreatic cancer. First author DOI 10.1186/s12885-023-11645-0↗
  3. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mes… Co-author DOI 10.1186/s12885-021-08388-1↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Carter Wright · 3 shared papers, 2021–2023 · strength 0.73
  2. Sara J. Cooper · 3 shared papers, 2021–2023 · strength 0.73
  3. Ryne C. Ramaker · 1 shared paper, 2021 · strength 0.16
  4. R Myers · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.